Uma Giri Selected Research

Uma Giri Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 03/2006
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 08/2011
6	Squamous Cell Carcinoma of Head and Neck 01/2019 - 05/2009
6	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2013
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019 - 04/2011
2	Carcinogenesis 01/2019 - 12/2013
2	Lymphoma (Lymphomas) 01/2011 - 11/2009
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Vascular Remodeling 09/2017
1	Circulating Neoplastic Cells 03/2016
1	Adenocarcinoma of Lung 08/2015
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2015
1	Hypoxia (Hypoxemia) 08/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2009
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 05/2009

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 09/2017 - 04/2011
3	MicroRNAs (MicroRNA)IBA 01/2019 - 05/2009
3	Messenger RNA (mRNA)IBA 01/2019 - 05/2009
3	Proteins (Proteins, Gene)FDA Link 12/2015 - 04/2011
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2015
2	Tyrosine Kinase InhibitorsIBA 07/2016 - 03/2016
2	Polo-Like Kinase 1IBA 07/2016 - 04/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 08/2011
2	PlatinumIBA 04/2016 - 08/2011
2	Pharmaceutical PreparationsIBA 07/2014 - 01/2013
2	Glutathione (Reduced Glutathione)IBA 01/2011 - 11/2009
1	NucleosidesIBA 01/2022
1	NADP (NADPH)IBA 01/2022
1	NucleotidesIBA 01/2022
1	GlutaminaseIBA 01/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2017
1	ErbB Receptors (EGF Receptor)IBA 07/2016
1	DNA (Deoxyribonucleic Acid)IBA 04/2016
1	vandetanib (ZD6474)IBA 04/2016
1	Docetaxel (Taxotere)FDA Link 04/2016
1	Circulating Tumor DNAIBA 03/2016
1	Dasatinib (BMS 354825)FDA Link 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 08/2015
1	Transcription Factors (Transcription Factor)IBA 08/2015
1	8-chloroadenosineIBA 01/2015
1	Adenosine (Adenocard)FDA LinkGeneric 01/2015
1	Biological ProductsIBA 12/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2014
1	Sorafenib (BAY 43-9006)FDA Link 12/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2014
1	Radiation-Sensitizing AgentsIBA 07/2014
1	Lysine (L-Lysine)FDA Link 12/2013
1	Histones (Histone)IBA 12/2013
1	Metformin (Glucophage)FDA LinkGeneric 01/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2011
1	AntibodiesIBA 04/2011
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 04/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2009
1	aziridine (ethyleneimine)IBA 11/2009
1	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 11/2009
1	Apoptosis Regulatory ProteinsIBA 05/2009
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 05/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2009

Therapy/Procedure

9	Radiotherapy 01/2021 - 03/2006
6	Therapeutics 01/2021 - 08/2011
3	Drug Therapy (Chemotherapy) 01/2021 - 08/2011
1	Aftercare (After-Treatment) 09/2016
1	Adjuvant Chemotherapy 08/2011